Cephalon named CFO Kevin Buchi chief operating officer with responsibility for worldwide pharmaceutical operations, worldwide technical operations, investor relations and business development. Buchi joined Cephalon in 1991 and became CFO in 1996. Replacing him as CFO is Wilco Groenhuysen, who was previously SVP finance.